IPAR · Nasdaq · CIK 0000822663

INTERPARFUMS INC

INTERPARFUMS INC’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 20, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.5B and net income of $168.4M, according to its XBRL data on EDGAR. Its EDGAR record lists 16 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.5B
Net income, FY2025
$168.4M
Form 4 filings on record, past 12 months
16

Company overview

Legal name (as filed)
INTERPARFUMS INC
Ticker
IPAR
SEC Central Index Key (CIK)
0000822663
Business address
NEW YORK, NY
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1556 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from INTERPARFUMS INC’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$879.5MFY2021$1.1BFY2022$1.3BFY2023$1.5BFY2024$1.5BFY2025
Net income
$87.4MFY2021$120.9MFY2022$152.7MFY2023$164.4MFY2024$168.4MFY2025
IPAR annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$879.5M$1.1B$1.3B$1.5B$1.5B
Net income$87.4M$120.9M$152.7M$164.4M$168.4M
Diluted EPS$2.75$3.78$4.75$5.12$5.24
Total assets$1.1B$1.3B$1.4B$1.4B$1.6B
Cash and equivalents$159.6B————

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

IPAR latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 10, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 20, 20268-KResults of operations; Regulation FD disclosure· period Oct 20, 2026Document · Index
Jul 31, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index

Recent SEC filings

The 40 newest documents filed by or about INTERPARFUMS INC, by form type:

8-K ×144 ×113 ×2144 ×23/A ×210-Q ×2DEFA14A ×1DEF 14A ×1ARS ×1SCHEDULE 13G/A ×110-K ×1NT 10-K ×14/A ×1
IPAR recent filings
FiledFormWhat it isOriginal
Oct 20, 20268-KResults of operations; Regulation FD disclosure· period Oct 20, 2026Document · Index
Sep 22, 20268-KOther events· period Sep 22, 2026Document · Index
Sep 17, 20268-KOther events· period Sep 17, 2026Document · Index
Sep 16, 20263/AInitial statement of beneficial ownership· period Sep 15, 2026Document · Index
Sep 16, 20263/AInitial statement of beneficial ownership· period Sep 15, 2026Document · Index
Sep 16, 20268-KShareholder vote results; Other events· period Sep 15, 2026Document · Index
Sep 16, 20263Initial statement of beneficial ownership· period Sep 15, 2026Document · Index
Sep 16, 20263Initial statement of beneficial ownership· period Sep 15, 2026Document · Index
Aug 27, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 27, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 27, 2026Document · Index
Aug 13, 2026DEFA14ADEFA 14ADocument · Index
Aug 4, 20268-KResults of operations; Regulation FD disclosure; Other events· period Aug 4, 2026Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 31, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index
Jul 31, 2026ARSARS· period Dec 31, 2025Document · Index
Jul 22, 20268-KResults of operations; Regulation FD disclosure· period Jul 22, 2026Document · Index
May 13, 20268-KAuditor change· period May 8, 2026Document · Index
May 5, 20268-KResults of operations; Regulation FD disclosure; Other events· period May 5, 2026Document · Index
May 5, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 21, 20268-KResults of operations; Regulation FD disclosure· period Apr 21, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 2, 2026Document · Index
Apr 2, 2026144Notice of proposed sale of securitiesDocument · Index
Mar 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 10, 202610-KAnnual report· period Dec 31, 2025Document · Index
Mar 3, 2026NT 10-KNT 10-K· period Mar 3, 2026Document · Index
Feb 24, 20268-KResults of operations; Regulation FD disclosure; Other events· period Feb 24, 2026Document · Index
Jan 29, 20268-KRegulation FD disclosure; Other events· period Jan 28, 2026Document · Index
Jan 29, 20268-KRegulation FD disclosure; Other events· period Jan 28, 2026Document · Index
Jan 26, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 23, 2026Document · Index
Jan 26, 20268-KOther events· period Jan 26, 2026Document · Index
Jan 23, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026Document · Index
Jan 23, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026Document · Index
Jan 21, 20268-KResults of operations; Regulation FD disclosure· period Jan 21, 2026Document · Index
Jan 7, 20264/AStatement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index
Jan 5, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 31, 2025Document · Index

Insider filing activity

16 Form 4 filings appear in INTERPARFUMS INC’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Perfumes, Cosmetics & Other Toilet Preparations

All 9 companies in Perfumes, Cosmetics & Other Toilet Preparations· Companies headquartered in New York

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000822663 and XBRL company facts. INTERPARFUMS INC on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.